Cyclerion Therapeutics (CYCN) Profit After Tax (2018 - 2025)
Cyclerion Therapeutics (CYCN) recorded quarterly Profit After Tax of -$976000.0 in Q3 2025, down 201.23% quarter-over-quarter from -$324000.0 in Q2 2025, and down 34.99% on a YoY basis from -$1.5 million in Q3 2024.
Cyclerion Therapeutics (CYCN) Profit After Tax (2018 - 2025) Analysis & Trends
Cyclerion Therapeutics' Profit After Tax history runs 8 years deep, the most recent figure standing at -$976000.0 for Q3 2025.
- In Q3 2025, Profit After Tax fell 34.99% year-over-year to -$976000.0; the TTM figure through Sep 2025 stood at -$2.2 million (up 58.36% YoY), while the FY2024 annual figure was -$3.1 million, up 75.72% from the prior year.
- Profit After Tax was -$976000.0 for Q3 2025 at Cyclerion Therapeutics, down from -$324000.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $530000.0 in Q4 2024 to a low of -$16.2 million in Q2 2021.
- Historically, Profit After Tax has averaged -$5.8 million across 5 years, with a median of -$4.3 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Profit After Tax tumbled 86.63% in 2022, then surged 131.29% in 2024.
- A 5-year view of Profit After Tax shows it stood at -$10.8 million in 2021, then surged by 59.88% to -$4.3 million in 2022, then jumped by 60.81% to -$1.7 million in 2023, then surged by 131.29% to $530000.0 in 2024, then plunged by 284.15% to -$976000.0 in 2025.
- The last three Profit After Tax figures came in at -$976000.0 (Q3 2025), -$324000.0 (Q2 2025), and -$1.4 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -56.74 Mn |
| 10 | Cyclerion Therapeutics | 11.50 Mn | 8.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -976,000.00 |
| Jun 30, 2025 | -324,000.00 |
| Mar 31, 2025 | -1.43 Mn |
| Dec 31, 2024 | 530,000.00 |
| Sep 30, 2024 | -723,000.00 |
| Jun 30, 2024 | -1.32 Mn |
| Mar 31, 2024 | -1.54 Mn |
| Dec 31, 2023 | -1.69 Mn |
| Sep 30, 2023 | -5.91 Mn |
| Jun 30, 2023 | -4.18 Mn |
| Mar 31, 2023 | -6.95 Mn |
| Dec 31, 2022 | -4.32 Mn |
| Sep 30, 2022 | -10.50 Mn |
| Jun 30, 2022 | -13.39 Mn |
| Mar 31, 2022 | -12.98 Mn |
| Dec 31, 2021 | -10.78 Mn |
| Sep 30, 2021 | -11.29 Mn |
| Jun 30, 2021 | -16.18 Mn |
| Mar 31, 2021 | -6.95 Mn |
| Dec 31, 2020 | -19.23 Mn |